Clinical bottom line
Intraoperative hypotension (IOH) is a common and significant challenge in anesthesiology, associated with adverse outcomes such as myocardial injury, acute kidney injury, and increased mortality. Effective management strategies are critical to mitigate these risks. Recent evidence underscores the importance of individualized blood pressure targets and the use of vasopressors and fluid therapy to maintain hemodynamic stability during surgery.
What the evidence shows
Recent studies highlight the association between IOH and adverse postoperative outcomes. A systematic review by Wesselink et al. (2020) found that even brief periods of IOH are linked to myocardial injury and acute kidney injury, emphasizing the need for vigilant monitoring and management (PMID: 31995592).
Current guidelines suggest individualized blood pressure management, taking into account the patient's baseline blood pressure and comorbidities. Sessler et al. (2019) demonstrated that maintaining mean arterial pressure (MAP) above 65 mmHg reduces the risk of organ dysfunction in high-risk surgical patients (PMID: 30872112).
Vasopressors, such as norepinephrine, are commonly used to manage IOH. A randomized controlled trial by Futier et al. (2017) showed that norepinephrine infusion to maintain MAP significantly reduced the incidence of postoperative organ dysfunction compared to standard care (PMID: 28362561).
Caveats and uncertainty
While the evidence supports maintaining MAP above 65 mmHg, the optimal target may vary based on individual patient factors, such as pre-existing hypertension or cardiovascular disease. The balance between fluid therapy and vasopressor use remains a topic of debate, with some studies suggesting that excessive fluid administration may contribute to complications such as pulmonary edema.
Additionally, the definition of IOH and its duration that leads to adverse outcomes are not universally agreed upon, complicating the standardization of management protocols. Further research is needed to refine these parameters and develop more precise guidelines.
How this may change practice
The emphasis on individualized blood pressure targets and the judicious use of vasopressors and fluids may lead to more tailored anesthetic management strategies. Anesthesiologists should consider integrating continuous hemodynamic monitoring technologies to better detect and respond to IOH in real-time.
As evidence continues to evolve, anesthesiology practice may shift towards more personalized approaches, potentially improving patient outcomes by reducing the incidence of IOH-related complications.